Jaguar Health Inc
NASDAQ:JAGX

Watchlist Manager
Jaguar Health Inc Logo
Jaguar Health Inc
NASDAQ:JAGX
Watchlist
Price: 5.38 USD 4.87% Market Closed
Market Cap: 88.2m USD
Section:
Wall Street Price Targets
Wall Street Price Targets
Revenue Forecast
Operating Income Forecast
Net Income Forecast
See Also
Price Target
Average
N/A
Revenue
Forecast
+2%
Operating Income
Forecast
0%
Net Income
Forecast
+1%

Wall Street
Price Targets

JAGX Price Targets Summary
Jaguar Health Inc

Wall Street analysts forecast JAGX stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for JAGX is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

JAGX Lowest Forecast
Wall Street Target
6.06 USD
13% Upside
JAGX Average Forecast
Wall Street Target
6.12 USD
14% Upside
JAGX Highest Forecast
Wall Street Target
6.3 USD
17% Upside
Lowest
Price Target
6.06 USD
13% Upside
Average
Price Target
6.12 USD
14% Upside
Highest
Price Target
6.3 USD
17% Upside
Jaguar Health Inc Competitors:
Price Targets
ELAN
Elanco Animal Health Inc
53% Upside
D
DHG
Dhg Pharmaceutical Joint-Stock Co
12% Upside
DMP
Dermapharm Holding SE
30% Upside
AGY
Allergy Therapeutics PLC
101% Upside
ELAN
Elanco Animal Health Inc
53% Upside
D
DHG
Dhg Pharmaceutical Joint-Stock Co
12% Upside
DMP
Dermapharm Holding SE
30% Upside
AGY
Allergy Therapeutics PLC
101% Upside
H
13
HUTCHMED (China) Ltd
58% Upside
A
AQST
Aquestive Therapeutics Inc
213% Upside
J
4015
Jamjoom Pharmaceuticals Factory Company SJSC
16% Upside
G
GLENMARK
Glenmark Pharmaceuticals Ltd
12% Upside

Revenue
Forecast

Revenue Estimate
Jaguar Health Inc

For the last 8 years the compound annual growth rate for Jaguar Health Inc's revenue is 57%. The projected CAGR for the next 3 years is 32%.

57%
Past Growth
32%
Estimated Growth
Estimates Accuracy
-16%
Average Miss
What are analyst estimates?

Operating Income
Forecast

Operating Income Estimate
Jaguar Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss
What are analyst estimates?

Net Income
Forecast

Net Income Estimate
Jaguar Health Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-100%
Average Miss
What are analyst estimates?

See Also

Summary
JAGX intrinsic value, competitors valuation, and company profile.
DCF Valuation
JAGX stock valuation using Discount Cash Flow valuation method.
Relative Valuation
JAGX stock valuation using valuation multiples.
Wall Street Estimates
JAGX price targets and financial estimates made by Wall st analysts.
Profitability Analysis
Detailed analysis of the company's profitability.
Solvency Analysis
Analysis of the financial position and solvency of the company.
Financials
Income Statement, Balance Sheet, Cash Flow Statement.
Discount Rate
JAGX stock discount rate: cost of equity and WACC.
Summary
DCF Valuation
Relative Valuation
Wall Street Estimates
Profitability Analysis
Solvency Analysis
Financials
Discount Rate
Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is JAGX's stock price target?
Price Target
6.12 USD

According to Wall Street analysts, the average 1-year price target for JAGX is 6.12 USD with a low forecast of 6.06 USD and a high forecast of 6.3 USD.

What is Jaguar Health Inc's Revenue forecast?
Projected CAGR
32%

For the last 8 years the compound annual growth rate for Jaguar Health Inc's revenue is 57%. The projected CAGR for the next 3 years is 32%.

Back to Top
ALPHA SPREAD
Follow us
Join more than 241,900+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2025 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.